Price $5.19 |
Market Cap
510.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.77
|
P/S
13.45
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-70.2K
|
FCF
-0.7
|
|
Op. Margin
-238.10%
|
Net Margin
-232.60%
|
ROE
-72.70%
|
ROI
-58.70%
|
|
ROA
-52.60%
|
EPS Growth
20.40%
|
Current Ratio
3.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.25 | - | - | 13.4M | Strong Buy |
| Acorda Therapeutics Inc (ACOR) | $16.16 | - | - | 957.3M | Strong Buy |
| Hanger Inc (HNGR) | $19.82 | - | - | 734.4M | Strong Buy |
| Medical Transcription Billing (MTBC) | $4.74 | - | - | 58M | Strong Buy |
| Champions Oncology Inc (CSBR) | $10.19 | - | - | 137.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
